Verteporfin plus Ranibizumab for Choroidal Neovascularization in Age-related Macular Degeneration: Twelve-month MONT BLANC Study Results

Larsen, Michael; Schmidt-Erfurth, Ursula; Lanzetta, Paolo; Wolf, Sebastian; Simader, Christian; Tokaji, Erika; Pilz, Stefan; Weisberger, Annemarie; MONT BLANC Study Group, (2012). Verteporfin plus Ranibizumab for Choroidal Neovascularization in Age-related Macular Degeneration: Twelve-month MONT BLANC Study Results. Ophthalmology, 119(5), pp. 992-1000. New York, N.Y.: Elsevier 10.1016/j.ophtha.2012.02.002

Full text not available from this repository. (Request a copy)

To compare the efficacy and safety of same-day verteporfin photodynamic therapy (PDT) and intravitreal ranibizumab combination treatment versus ranibizumab monotherapy in neovascular age-related macular degeneration.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Head Organs and Neurology (DKNS) > Clinic of Ophthalmology

UniBE Contributor:

Wolf, Sebastian

ISSN:

0161-6420

Publisher:

Elsevier

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 14:22

Last Modified:

17 Mar 2015 20:59

Publisher DOI:

10.1016/j.ophtha.2012.02.002

PubMed ID:

22424834

Web of Science ID:

000303399800016

URI:

https://boris.unibe.ch/id/eprint/7551 (FactScience: 212839)

Actions (login required)

Edit item Edit item
Provide Feedback